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Abstract: Emergence and reemergence of infectious diseases pose significant public health risks that are continuously haunting
human civilization in the past several decades. Such emerging pathogens should be considered as a high threat to humans, animals,
and environmental health. The year 2020 was welcomed by another significant virus from family Coronaviridae called severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus disease 2019 (COVID-19). The disease was first reported
in the city of Wuhan, Hubei province, China. Within a short time, this disease attained the status of the Public Health Emergency of
International Concern. Presently, COVID-19 has spread to more than 150 countries, therefore, the World Health Organization (WHO)
called it a pandemic. The Chinese government, along with WHO, other health agencies, and many nations, are monitoring the current
situation closely to analyze the impact of SARS-CoV-2/COVID-19 on humans, animals, and environmental health. In the context of
the current situation, biosafety and biosecurity measure that focus on One Health aspects of the disease outbreaks and the SARS-CoV-2
spread are of great importance to restrain this pathogen. Along with these efforts, standard precaution and control measures should also
be taken at personal and community level to prevent the spreading of any contagion diseases, including COVID-19. Researchers are
putting their very high efforts to develop suitable vaccines and therapeutics/drugs to combat COVID-19. This review aims to highlight
the importance of biosafety, biosecurity, One Health approach, and focusing on recent developments and the ways forward to prevent
and control COVID-19 in a useful way.
Key words: COVID-19, SARS-CoV-2, 2019-nCoV, current scenario, biosafety & biosecurity

1. Introduction
Emergence and reemergence of few potent and highly
infectious diseases are posing significant public health

risks that are haunting human civilization continuously,
thereby posing a considerable threat to the lives of humans
as well as animals all around the world.

* Correspondence: muhammadkhan1985@gmail.com
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Historically, many deadly disease outbreaks have
happened, few due to the mutations of the infectious
pathogens, cross-species jumping of the microbes, and
the majority of these were linked to zoonotic origins, and
others may be due to evolving newer and novel and even
highly pathogens (Table 1). The threats of such diseases can
arise in any country and nations across the world. Previous
studies have shown that 60% of the infectious diseases and
70% of emerging infections of humans have originated
from zoonotic origins (WHO, 2020a). This might be due
to unplanned urbanization, following integrating animal
husbandry practices, increased contact with animals, and
food-habits to consume different kinds of animals, poultry,
and wildlife animal species (Mourya et al., 2019; Salata et
al., 2020).
In recent times, the world has experienced deadly
disease outbreaks such as severe acute respiratory
syndrome-related coronavirus (SARS-CoV), Middle
East respiratory syndrome-related coronavirus (MERSTable 1. Highly pathogenic viruses and dealing recommended
biosafety levels.
Viruses

Risk groups Recommended laboratory

Ebola

4

BSL4

Nipah virus

4

BSL4

Hendra virus

4

BSL4

Chikungunya

3

BSL3

Japanese encephalitis 3

BSL3

SARS-CoV-2

3

BSL3

Hantavirus

3

BSL2

HPAI H5N1

3

BSL2

HIV

3

BSL2

MERS-CoV

3

BSL2

SARS-CoV

3

BSL2

West Nile

3

BSL2

Dengue

2

BSL2

Zika

2

BSL2

CoV), bird flu, swine flu, Ebola, Zika, Nipah, and now
facing the most recent threats of coronavirus disease 2019
(COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) (Dhama et al., 2012; Munjal
et al., 2017; Dhama et al., 2018; Singh et al., 2019; Dhama
et al., 2020a; Malik et al., 2020; Rodriguez-Morales et al.,
2020).
On December 31, 2019, 27 pneumonia cases of
unknown aetiology had been reported by the Wuhan
Municipal Health Commission, Hubei province, China.
On January 7, 2020, the pathogen was confirmed as SARSCoV-2, previously known as a novel coronavirus (2019nCoV). Although other vector-borne diseases, zoonotic
diseases, and snake bites are still matter of concern,
COVID-19 became a pandemic, as declared on March
11, by the World Health Organization (WHO). Currently,
COVID-19 has spread to more than 180 countries/regions
(Coronavirus COVID-19 Global Cases, 2020). The
disease has been reported to be initially transmitted from
animals to humans, and then acquired efficient human
to human spread in a rapid way (Ahmad et al., 2020a).
The transmission cycle of SARS-CoV-2/COVID-19 is
presented in Figure 1.
At present, there are not commercially marketed
effective COVID-19 specific vaccines or antiviral drugs
at our disposal. Hence, the current scenario warrants the
enforcement of strict preventive and control strategies for
minimizing the rapid spread of this fatal pathogen across
the globe (Dhama et al., 2020b). Previously published
literature suggests that the laboratory capacity, treatment,
and diagnostic facilities were found to be inadequate
in limited-resources countries (Heckert et al., 2011).
One Health approach is needed for active investigation,
prevention, and diagnosis of COVID-19 (Ahmad and
Hui, 2020a). In the context of zoonotic diseases that affect
both human and animal populations, it is a necessity that
both human and veterinary experts must work together in
cordial and cooperative networking modes.
The source of the SARS-CoV-2 is very likely related to
a wild animal, and there is a dire need for strict laws to
limit wildlife markets to control the occurrences of new

Figure 1. Transmission flow of COVID-19.
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emerging zoonoses in the future (Wang et al., 2020). We
know that biosecurity and biosafety are not the issues that
can be addressed by only researches but need practical
strategies and training in handling infectious pathogens
and disease outbreaks situations across the global scenario
(Dhama et al., 2013; PRC, 2020).
Therefore, looking into the future, we must continue
to work together on an international level with high
collaborative, cooperative, and networking efforts by
adopting rapid means of communications and updates
as well as supported with adequate health infrastructure,
medicines, and intensive care units. A balanced and
practical approach to global biosafety can be achieved
only by recognizing the many viewpoints and approaches
to biosecurity and biosafety procedures implemented
effectively around the world to create a safer world of
today and for the next generations to be safeguarded from
any adverse health events of disastrous outbreaks such
as SARS-CoV-2/COVID-19. For better understanding
this purpose, we must shift our perception from national
responsibilities to one of a global responsibility from the
viewpoint of national, global, One Health approaches
that may encourage all the entire community to share
their experiences and bring safety at present and future.
Researchers and health agencies across the globe are
making continuous high efforts to check and combat
the spread of this virus, along with developing effective
vaccines and therapeutics/drugs (Ahmad et al., 2020b).
The present review describes in brief some salient
features and aspects of biosafety, biosecurity, and One
Health approaches, and their usefulness, potent roles, and
applications to restrain/contain and counter COVID-19
disease outbreaks, and check the further spread of this
emerging disease.
2. COVID-19 as a global threat
SARS-CoV-2/COVID-19 is a severe threat to public
health as a pandemic. Also, factors such as high human
migration, air traffic, and trade between China and other
countries pose risks. Some of the countries in Africa
are under high risk of introduction and spreading of
the COVID-19 (Nkengasong, 2020; Nkengasong and
Mankoula, 2020). Primarily the travellers from China have
imported COVID-19 cases to other countries such as the
United States of America (USA) (Jernigan, 2020). The first
case of COVID-19 outside mainland China was reported
in Thailand (Today, 2020). In the Africa continent, the first
case was reported in Egypt (WHO, 2020b). The COVID-19
outbreaks have created extra pressure on the world health
systems to invest heavily in diagnosis, treatment, and
for controlling the spread of disease, as well as to check
the zoonotic risks. On the other side, the oil demand at

134

a global level has been struck by COVID-19 outbreaks.
Also, trade, business, movement, tourism, and other daily
activities are slowdown and affecting companies around
the world, including Nissan and Apple, and considered
to be the most significant danger to the global economy
(WEF, 2020). In low economic countries, the laboratory
capacity is insufficient, and these facilities are poorly
maintained (The PLoS Medicine Editors, 2007; Kruk, 2008;
Wertheim et al., 2010; WHA, 2020). Therefore, to diagnose
and treat such highly infectious pathogens such as (SARSCoV-2/COVID-19), which can cause deadly diseases in
humans, need well-established biosafety and biosecurity
laboratories as well as the adoption of appropriate One
Health approaches.
3. Laboratory biosafety
The WHO describes the laboratory biosafety as the word
used to define technologies, containment principles, and
practices that are applied to stop unintentional exposure
to toxins and pathogens or their accidental release.
Furthermore, the laboratory biosecurity is described as
the institutional and personal security procedures planned
to inhibit the loss, misuse, diversion, theft, and intentional
release of toxins and pathogens (WHO, 2020c).
3.1 Laboratory biosecurity
Laboratory biosecurity is more than merely a kind of
physical security. It also contains personnel-management,
material accountability and control, transportation
security, information security, and program management
(Salerno et al., 2007). A biosafety laboratory (BSL)
comprises a set of safety measures mandatory for handling
hazardous biological agents in a secure, safe, and enclosed
control setting (Table 1). Mainly, a BSL contains primary
protective barrier means safety- equipment, and a
secondary protective barrier means for safety facilities.
There are 4 protection levels of biosafety laboratory
designed to handle suitable pathogens in vitro named as
BSL-1, BSL-2, BSL-3, and BSL-4 (Table 1); contrastingly,
facilities designed to handle suitable pathogens in in-vivo
experiments are named as animal biosafety laboratory
(ABSL-1, ABSL-2, ABSL-3, and ABSL-4 (Zhiming, 2019).
These biosafety levels based on the construction, design
structures, equipment, containment facilities, standard
practices, and operational techniques are warranted while
working with various infectious and deadly agents of
different risk groups.
BSL-1: It needs no special restraint equipment and is
used for well-characterized agents not identified to cause
infections in healthy humans and that have an insignificant
possible threat to the environment.
BSL-2: BSL-2 is applicable for dealing pathogenic
agents related to human infections that are less pathogenic
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and for which preventive and therapeutic mediations are
available.
BSL-3: BSL-3 is designed for dealing with pathogenic
agents that can cause severe infections and deadly diseases
in humans. This level represents those pathogenic agents
who are having high individual risks but low community
risks. For this group, pathogenic agents, preventive, and
therapeutic mediations may be available. To work in
BSL-3, scientists and researchers need to wear the proper
protective clothing and equipment in negative pressure
rooms.
BSL-4: BSL-4 is the extreme control laboratory that
is designed and constructed for the dealing of highly
pathogenic and dangerous biological agents that can
cause severe and deadly infections in humans. This
level represents pathogenic agents who are having high
individual and community risks. Mostly for this group,
no preventative or therapeutic interventions are available.
For the researchers who are working in BSL-4 laboratory
it is mandatory to wear positive pressure personnel suits
(WHO, 2020c; CSNC, 2020).
4. Biological threats to One Health
Infectious disease agents and toxins constitute noteworthy
threats to the economy, biodiversity, food security, food
safety, and public health. Therefore, integrating veterinary
and human public health surveillance and monitoring
efforts are essential to control such deadly infectious
agents which could pose pandemic threats and put billions
of human populations at high risks for their survival
(Rabinowitz et al., 2006). The WHO recognizes zoonoses
as emerging threats and defines them as phenomena which
have an increasing trend and tendency of expansions in
different geographical regions, hosts, or vector’s range. As
the global human population increases, the probability of
zoonotic pathogen transmissions from animals to humans
increases with anthropological pressures on animals and
the environment (Singh, 2009; Bonfoh et al., 2010). The
problem of not adopting adequate biosecurity measures
is most acute in animal husbandry practices including of
livestock and poultry production, especially the threats
posed from transboundary animal diseases (TAD),
relevant to endemic diseases such as Peste des petits
ruminants (PPR), bluetongue, swine fever, infectious
pustular vulvovaginitis (IPV), caprine encephalitis (CAE),
maedi-visna, equine piroplasmosis, rhinopneumonitis
of the equine, bovine viral diarrhea (BVD), bovine
immunodeficiency (BIV), and few others. Such pathogens
are responsible for causing enormous economic losses,
and therefore need to have strategies for biosecurity in
place to be strictly executed. Therefore, efforts to prevent
pandemic diseases, categorized into external biosafety and

internal biosecurity, need to be aimed at preventing the
spread of infection (FAO, 2008; Singh, 2009).
With more livestock and animal products moving
longer distances in shorter periods and rising concentration
of food production to fewer countries and production
companies, the world is becoming increasingly vulnerable
to the adverse effects of animal diseases. Endemic animal
diseases in some of the world’s poorest countries are a
constant threat to health and agriculture, hampering
economic and social development, and reducing food
availability (WOAH, 2015).
The Centers for Disease Control and Prevention (CDC)
USA, planned to combat biological terrorism attacks
and develops guidelines for investigating and assessing
suspected human clusters and animal diseases or injury,
and triggers for notifying law enforcement of prevention,
control and restricting possible biological or chemical
terrorism incidents and threats (Rabinowitz et al., 2006).
Similarly, biological terrorism has increased the number
of sick or dead animals, and biological warfare agents can
intoxicate these animal disease outbreaks triggered by
bioterrorism agents to a wide variety of hosts (Rabinowitz
et al., 2006). In the context of the current epidemic of
COVID-19, the One Health approach should be of great
importance (Ahmad and Hui, 2020b). A diagrammatic
representation of the One Health approach is presented in
Figure 2.
5. Highly pathogenic emerging viruses
Emerging viruses are those viruses that have caused
disease outbreaks in the past 2 decades of the 21st century.
These emerging viruses are also defined as those viruses
which have posed probable threats of disease outbreaks
in the coming years. Emerging viruses consist of those
viruses that are detected in people as a new or the ones
that may have been existing earlier but are now increasing
at a higher rate in the global population (Morens et
al., 2004; Howard and Fletcher, 2012). Some of the
examples of highly emerging viruses are avian influenza
(HPAI) virus of subtype H5N1, Ebola virus, Middle
East respiratory-syndrome coronavirus (MERS-CoV),
severe acute respiratory syndrome (SARS), Chikungunya
virus, Zika virus, Japanese encephalitis virus, West Nile
virus, Hantavirus, Hendra virus, and Nipah virus. These
highly pathogenic viruses cause diseases which are highly
threatening animal and human health (Morens et al., 2004;
Jones et al., 2008). In the context of the above statement,
SARS-CoV-2 is also a deadly pathogenic virus that caused
a considerable risk to public health and accounted for very
high economic losses in a short period of 2 months.
5.1. Biosecurity for dealing pathogenic emerging viruses
For working on pathogenic microorganisms, it is essential
to have proper biosafety and biosecurity laboratories.
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Figure 2. One Health approach, modified from Ahmad and Hui (2020).

The purpose of biosecurity is to prevent the spreading
out of the emerging pathogenic viruses from the safety
laboratory into the outside environment. In the biosecurity
laboratory, there should be specific professional working
groups, which may include science directors, principal
investigators, professional laboratory staff, administrators,
facility maintenance personnel, laboratory safety officers,
law enforcement agencies, and security staff (CDCP,
2009). The biosecurity laboratory contains a system of
a multidimensional approach, which includes physical
building security, biohazard material accountability and
control, personnel security, information security, and
transport security (Gaudioso and Zemlo, 2007). Table
2 is presented with a list of highly pathogenic viruses
Table 2. Animal’s impact on human health around the globe:
enlisted diseases are vector-borne diseases, zoonotic diseases,
and snake bites.
Death/year

People affected/year

Vector-borne diseases

1.0 million

1.0 billion

Malaria

0.6 million

500 million

Dengue

20,000

50–200 million

HIV

1.5 million

35 million

Gastrointestinal

1.23 million 1.7 million

Zoonotic diseases

Tuberculosis (zoonotic) 0.1 million

0.55 million

Rabies

70,000
0.4 million–2.4
million

Snake bites
Worker
Commercial fishing
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70,000
20,000 to
11,000
24,000

including SARS-CoV-2, and dealing with recommended
laboratories/facilities.
6. Epidemiology, surveillance and monitoring–current
positions and focusing a need to be enhanced
The concept of public health surveillance is widely used
in modern days with its contribution to provide data and
information, assess, characterize and study the distribution
of diseases and health adverse events, identification of
emerging health conditions, prioritize public health
actions, and monitor the control and prevention activities.
In recent years, scientific advances in public health
surveillance, rapidly evolving technologies, and changing
health care requirements are of great importance. However,
researchers and public health professionals continue to
pursue developing new methods to evaluate and improve
the ability of public health and disease surveillance systems
to support new uses of data. Researchers are interested in
the early recognition and management of chronic diseases
(Makam et al., 2013; Groseclose and Buckeridge, 2017).
In the context to support early detection of public health
events and diseases, the syndromic surveillance system
was introduced to alert at very low thresholds. Also, the
practitioners and public health professionals have tried to
improve the accuracy of syndromic surveillance systems
by comparing results from different surveillance systems
and modifying statistical outbreak detection algorithms
(Cadieux et al., 2012; Groseclose and Buckeridge, 2017).
Disease and public health surveillance are critical for
public health, to timely recognize and collect data
of public health events and outbreaks efficiently and
effectively. In the context of the current epidemics of
COVID-19, the epidemiological approaches, preventive

AHMAD et al. / Turk J Biol
strategies, extending disease surveillance at national and
international level is essential to contain this disease that
has created havoc and posed threats to the survival of
humankind.
7. Role of bats and other animals in SARS-CoV-2
The recently emerged COVID-19 has been linked with a
local live animal and seafood market in China (Perlman,
2020). It has been identified that apart from other various
coronaviruses (CoV) hosts, bats and birds are the ideal
hosts for CoVs. Alphacoronavirus and Betacoronavirus
were identified in bat CoVs, while Gammacoronavirus
and Deltacoronavirus dominate in bird CoVs (Woo et
al., 2012; Liu et al., 2016). Likewise, in the phylogenetic
analysis, it has been shown that MERS-CoV is closely
linked to Betacoronavirus found in bats of Europe and
Africa. Similarly, other examples of bat viruses that
are found in humans and agricultural animals as their
secondary host are filoviruses (Marburg virus and
Ebola virus), porcine epidemic diarrhea (PEDV) virus,
and henipaviruses (Nipah and Hendra viruses) (Moratelli
and Calisher, 2015).
However, since the first outbreak of COVID-19,
intense research studies have been done to identify the
source of origin of its causative agent (SARS-CoV-2).
Paraskevis and colleagues, by using phylogenetic analysis,
determined that COVID-19 is closely related to the Bat
CoV RaTG13 sequence throughout its genome with a
similarity index of 96.3%. However, especially in the
middle region of nucleotide, almost half of the spike region,
both COVID-19, and RaTG13, grouped in the form of
separate distant lineage (sarbecovirus branch) (Paraskevis
et al., 2020). Nevertheless, as bat population constitute a
genetically diverse group and studies have shown that one
species of a bat may not represent the other species of bats.
However, the myth of the exact mechanism of the spread
of the SARS-CoV2 virus is elusive and unclear. Therefore,
to gain a deeper understanding of the microbe coevolution
of a bat, its immune system and ecological interaction
need to be unrevealed. Collaboration between state-ofthe-art laboratories across the globe should make efforts
to develop cell lines from particular tissues and reagents of
a bat and initiate a setup of bat colonies in a laboratory for
better understandings of microbe-host interaction in these
ecological mammals.
Both the initial origin and the primary route of
transmission in the case of the COVID-19 outbreak are
both still unknown. Since the first cases were reported
from the live-markets in Wuhan, wild animals sold in the
market might have played a possible role in the origin of the
SARS-CoV-2 virus. Taking into consideration the possible
involvement of an intermediate host, a temporary ban

was imposed on the wildlife trade in China (Harypursat
and Chen, 2020; Mallapaty, 2020). COVID-19 outbreak
can also occur, employing the primary food-borne route,
which is then further transmitted by the respiratory way
among human beings (Jalava, 2020). The predecessor of
SARS-CoV-2 was found to have originated from bats.
Investigations conducted in the SARS and MERS CoVs
outbreaks identified civets and dromedary camels as their
intermediate hosts that played a significant role in the
disease transmission to humans (Park et al., 2020).
Advanced genomic analysis has pointed out that
SARS-CoV-2 is closely related to the bat CoV that was
previously isolated from horseshoe bat, the same species
of bat that was found to harbor SARS-related CoVs by
acting as its maintenance hosts. Hence, we cannot rule out
the possibility of SARS-CoV-2 emergence as a sequel of
sequential recombination occurring among the precursors
of SARS-related coronaviruses. This is the reason for
the extensive search of an intermediate animal host in
COVID-19 that is responsible for the zoonotic spillover
from bats to humans (Murdoch and French, 2020). It is
very much essential to make a big decision regarding the
trade of wild animals in China to prevent the possibility of
future outbreaks due to zoonotic spillover. However, a total
ban on the wild animal trade is not a practical solution as it
will affect the livelihood of a substantial proportion of the
Chinese population. Hence, such a move will only have a
negative effect since it will shift the trade of wild animals
to the black market (Mallapaty, 2020).
8. Diagnosis of COVID-19
According to the new policy of the Food and Drug
Administration (FDA), it can issue an Emergency Use
Authorization (EUA) for specific laboratories seeking
to develop diagnostic tests to develop a rapid diagnostic
testing method and facility to detect SARS-CoV-2. On
February 4, 2020, the Secretary of Health and Human
Services (HHS) determined that COVID-19 is a public
health emergency, and the current circumstances exist for
justifying the authorization of emergency use of in vitro
diagnostics (FDA, 2020). Initially, the SARS-CoV-2 was
isolated from a clinical sample, and within weeks many
sensitive and reliable diagnostic tools were developed
and deployed across the country. Furthermore, China has
shared the information on viral sequences, PCR primers,
and probes with the international community and
WHO to facilitate further investigations and research on
COVID-19. The virus sequence was uploaded to GISAID
Database. On February 23, 2020, the National Medical
Product Administration (NMPA), China has approved
10 detection kits used for COVID-19 diagnosis including
virus sequencing product (01), isothermal amplification kit
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(01), colloidal gold antibody detection kits (02), and RTPCR kits (06). The rapid serological diagnostic kit is being
developed but not widely used (Report, 2020). Detection
of SARS-CoV-2 from respiratory secretions Quantitative
Real-time RT-PCR (RT-qPCR) assay has routinely been
used. Besides, more than 7 types of diagnostic kits have
been developed for the detection of the nucleic acid of
SARS-CoV-2. In the context of the current situation in
China, especially in Hubei province for management of
the outbreak, a combination of RT-qPCR or NGS and
clinical criteria may be more critical.
Studies have found that asymptomatic patients secrete
similar viral load when compared to symptomatic patients.
This is critical since the transmission capacity of minimally
symptomatic or asymptomatic COVID-19 patients
is very high and equally comparable to symptomatic
patients indicating that the transmission can occur early
in the course of infection (Zou et al., 2020). Diagnosis
of COVID-19 is based on the detection of nucleic acids
from the samples such as throat swabs, sputum, saliva,
lower respiratory tract secretions, stool, blood, tears, and
conjunctival secretions (Shen et al., 2020; To et al., 2020;
Xia et al., 2020). In a recent study, anal swabs were found
to give more positive results in the later stages of the
infection compared to the oral swabs (Zhang et al., 2020).
Hence, the clinicians and lab workers should take extra
precautions while handling test samples even in the case of
negative oral swab test results due to the possible fecal-oral
transmission in COVID-19.
Compared to the respiratory samples, the viral loads
in stool samples were found to be less. Still, precautionary
measures need to be followed while handling the stool
samples since the possibility of disease transmission
remains the same (Pan et al., 2020). The live virus was also
detected in the self-collected saliva of patients infected
with COVID-19; hence saliva can be considered as an ideal
sample due to the noninvasive nature of sample collection
technique for the diagnosis of COVID-19 infection in
suspected individuals (To et al., 2020). The presence of
SARS-CoV was also identified in the tears and conjunctival
secretions of COVID-19 infected patients. Among the
study population, only one sample that is obtained from
COVID-19 patients with conjunctivitis gave positive RTPCR results (Xia et al., 2020). This indicates the possibility
of disease transmission through tears and conjunctival
secretions in COVID-19 patients with conjunctivitis. The
patients exhibiting clinical signs of COVID-19 may not
test positive in nucleic acid detection tests at every stage
of the disease. Both the positive and negative test result of
patients exhibit almost similar clinical symptoms, thereby
increasing the possibility of misdiagnosis or missed
diagnosis. The only difference that observed in patients
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with positive test result is that they tend to have dyspnea
(Li et al., 2020).
Key factors: community containment, social
distancing, isolation, and quarantine to prevent the spread
and transmission of COVID-19.
Isolation: Isolation is the separation of sick peoples
from healthy peoples.
Quarantine: Quarantine is the movement restriction of
peoples, often with fever investigation, of contacts when it
is not evident whether they have been infected and not yet
symptomatic.
Community containment: Community containment
comprises procedures that range from increasing social
distancing to wide-ranging community quarantine.
The COVID-19/SARS-CoV-2 is believed to be
primarily transferred by respiratory droplets with similar
generation time and incubation time as SARS coronavirus
(SARS-CoV) (Zhu et al., 2019; Wilson and Chen, 2020).
SARS-CoV was alarming at that time, maybe even
more terrifying compared to COVID-2019, given its
much more common progression of sickness and death.
Nevertheless, the precise pieces of evidence were capable
of absolutely interrupting human to human transmission,
to end the epidemic, and therefore, SARS-CoV is now
eliminated. In the absence of antivirals and vaccines, this
significant success was only possible because of the strict
implementation of appropriate and timely prevention
and control strategies along with suitable public health
measures and awareness programs (Wilder-Smith and
Freedman, 2020).
China again faced with the same situation of a
coronavirus outbreak with a closely related virus-like
SARS-CoV for which currently no specific vaccines
and medicines exist. Still, time is needed to implement
classical public health measures to control the epidemic
of COVID-19, which causes a potentially life-threatening
respiratory disease. The primary goal of public health
procedures is to separate people in order to minimize
the risks of the spread and prevent person to person
transmission of this virus. The measures by which we can
control and reduce the chances of transmission and check
to spread of COVID-19 are community containment,
social distancing, isolation, and quarantine. The Chinese
government has implemented all these measurements for
the effective control of COVID-19. In order to offer quick
responses to the outbreaks of COVD-19 and immediately
implement all the necessary measures within a week to
minimize the risks of transmission and control the spread
of this viral infection, following case detection, immediate
isolation and contact tracing are implemented and medical
follow-ups and intensive care are provided to all the people
affected (Wilder-Smith and Freedman, 2020).
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9. Public recommendations for avoiding the unprotected
contact with both farm and wild animals
In Wuhan, China, the newly discovered COVID-19
disease outbreaks triggered and alarmed a health official
around the world to start issuing advisories that provided
necessary steps that people could take to help reduce
the risks of this CoV infection. Many of the suggested
preventive precautions require some simple commonsense, preventive health methods which can be best
practiced at all times, such as washing hands with soap/
detergent, water and disinfectant, covering the mouth
during coughing or sneezing, avoiding close contact with
individuals experiencing clinical symptoms and following
appropriate kitchen practices while cooking animalbased food items thoroughly (Khan and Naushad, 2020;
Moritsugu and Miller, 2020).
At a seafood and meat market in Wuhan, China, where
live animals were slaughtered and sold as food, the new
virus appears to have jumped from wildlife to humans. That
was a familiar story of the SARS-CoV outbreak, which was
also caused by a coronavirus started eating a catlike animal
called then palm civet in China. The MERS-CoV epidemic
began and was transmitted from dromedary camels into
humans in the Middle East. Conservationists see a lesson
on public health in the spread of yet another coronavirus.
The WHO issued a coronavirus-related graphics of animals
warned against unprotected sex with wild animals. It is of
great importance to avoid unsafe interaction with wild life
or farm animals (vanUhm, 2016; Mikkelson, 2020).
A common way in which people can get infected
with germs that can cause zoonotic diseases is the close
connection between humans and animals, including direct
contact, encountering the saliva, blood, urine, mucous,
feces (waste), or other body fluids. Examples include
animals being petted or handled, and bites, or scratches:
indirect contact where the animals are living and moving,
or artefacts or surfaces contaminated with germs.
Examples also include water from the aquarium tank, pet
habitats, chicken coops, barns, trees, and soil, and pet food
and water dishes. While some people eat or drink anything
unhealthy, like unpasteurized (raw) milk, undercooked
meat or eggs, or fresh fruits and vegetables tainted with
infected animal feces (CDCP, 2020). Contaminated food
can cause disease in both humans and animals, including
poultry. Everyone, including healthy people, can get sick
from the zoonotic disease. Some individuals, however, are
at higher risk as compared to others and need to adopt
appropriate necessary steps to protect themselves or their
family members from zoonotic efforts. Some persons are
more likely to get sick and may even die from infection of
certain diseases than others, such as children younger than
5 years, individuals older than 65 years, individuals with

weak, compromised immune systems (immunosuppressed
persons), and pregnant women in particular.
10. Live-animal markets to be avoided which are posing
novel zoonotic pathogens threats, public health risks
during an outbreak
A pathogenic microorganism (bacteria, virus, parasite,
or fungus) that is carried by animals and transferred to
humans is called zoonosis or zoonotic disease (Brucker,
2020). The disease presents mild symptoms of respiratory
infection, the same as occurs in the common cold. Still,
sometimes this zoonosis or zoonotic disease can be so fatal
and lethal that it could cause a pandemic. The significant
sources implicated in zoonosis are animal vector-borne
diseases, zoonotic diseases, snake bites, and tick (Scanes,
2020). According to CDC, the primary food sources that
cause food-borne diseases and result in hospitalization
are associated with meat, dairy, poultry, beef, and pork
consumption, with proportions of 45.5%, 11.5%, 5.4%,
and 5.1%, respectively (Painter, 2013).
Similarly, molluscs (oysters and mussels) are filter
feeders, and pathogens are accumulated in these, and
hence there is a risk of foodborne diseases (Grodzki et al.,
2012). Noroviruses were detected in oysters in Europe,
likewise as in cattle, and pigs are identified rotaviruses,
and these animals are considered as the primary source
of zoonotic infections (Midgley et al., 2012). According to
the previous research findings and related to the current
scenario of COVID-19, it has been recommended by
Chinese health authorities to avoid visits to live-animal
markets. In this regard, the unknown current source of
the epidemic might be animals or birds until or unless the
cause of disease transmission is found.
11. Tips, guidelines, and policy pertinent to travellers,
general public/and prevention of infectious disease
Chinese health officials have confirmed thousands of
COVID-19 affected cases in China, with the virus widely
spreading in many parts of the country from person to
person. COVID-19 cases, most of which are associated with
travelling from Wuhan, are also being reported in a growing
number of international locations (NCIRD, 2020). There is
currently no vaccine or drug available for COVID-19. In
such a scenario, the community-based interventions such
as school dismissals, event cancellations, social distancing,
and the creation of staff plan to work remotely can help
slow down the spread of COVID-19. Individuals can take
daily preventive measures, such as frequent hand washing,
staying at home when they are sick and coughing and
sneezing (CDC, 2020; Wu and McGoogan, 2020). Such
infections may lead to severe symptoms in individuals
having a weak immune system, older aged people, and
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Figure 3. Standard precautions to prevent the spread of SARS-CoV-2/COVID-19.

those suffering from long-term illnesses such as diabetes,
cancer, and chronic lung diseases (MacLaren et al., 2020;
GOV.UK, 2020). Self-observation means that people
should remain alert to subjective fever, cough, or difficulty
in breathing so that they can timely contact the nearest
health care providers or their local health departments
immediately to determine whether a medical assessment
is needed.
Therefore, the patient should be monitored for fever by
taking temperatures twice a day and need to remain alert to
coughing or difficulty in breathing. The State or local public
health authority shall be responsible for assessing exposed
persons for the presence of fever, cough, or difficulty in
breathing and high-risk exposures, as recommended by
CDC for this communication to occur at least once in a day
(CDC, 2020; Habibi et al., 2020). The COVID-19 disease
also spreads from person to person. Therefore the isolation
and quarantine of a person or a group of people known
or reasonably believed to be infected with communicable
disease and potentially infectious from those who are not
infected to prevent the spread of infectious disease not yet
symptomatic are warranted to check its spread (Brooks
et al., 2020; Rasmussen et al., 2020). Controlled travel
includes excluding long-distance commercial aircraft,
ships, trains, and buses, and continuous monitoring of
travel should be coordinated with public health authorities.
Moreover, avoid setting up close to congregate settings
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(public places), such as shopping malls, movie theatres,
arenas, offices, schools, and classrooms (CDC, 2020).
12. Prevention and control of COVID-19
It is of great importance to stop further spreading of
SARS-CoV-2/COVID-19, for this purpose the standard
precautionary measurements should be followed, as
presented in Figure 3. The COVID-19 has kept alert the
entire health institute across China and also at a global
level as it can spread from person to person. Therefore,
massive control strategies and appropriate responses and
preparedness plans have been implemented (Daszak et al.,
2020). Since the outbreak occurred, there is no vaccine
or specific antiviral treatment to prevent COVID-19.
However, prevention and control strategies received at
the community level have become helpful by reducing
the transmission routes of the disease. The SARS-CoV-2
nucleic acid is used as a detected method for specimens,
including nasopharyngeal swabs, sputum, lower
respiratory tract secretions, blood, and stool (Zhou et al.,
2020).
Prevention and control of the transmission of
COVID-19 is a crucial issue for health workers for proper
management and checking the outbreaks of this emerging
disease. The primary mode of communication of COVID-19
infection is through direct contact from person to person
or exposure to infectious persons through the respiratory
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droplets or fomites. Therefore, it is recommended to
maintain necessary good personal and environmental
hygiene practices and to implement stringent avoidance
of the contact and droplet precautions among health care
workers, which can reduce the cumulative incidences of
the COVID-19. To prevent community transmission,
contact tracing, quarantine/isolation of close contacts, and
public education are the essential measures that should be
carried out, besides implementing droplet precautions and
contact precautions seem adequate to reduce the risks of
SARS-CoV-2 virus infection.
Hence it is recommended to avoid close contact
with affected people/infected individuals, not to touch
eyes, nose, and mouth frequently, cover-up cough, or
sneeze with a tissue, after that, dispose of the used tissue
in the dustbin. Added to this, appropriate cleaning and
disinfection procedures should be followed frequently for
touched/contaminated objects, fomites, and surfaces by
employing standard and regular household cleaning and
disinfectant sprays or wipes, besides the recommendations
of WHO, China CDC for COVID-19 outbreak should also
be followed. Furthermore, exposure to patients with mild
SARS-CoV infection, airborne precautions (hand hygiene,
gown, gloves, N95 masks, and eye protection) should be
implemented if aerosol-generating procedures are to be
undertaken measurement among the community and
health workers (Seto et al., 2013).
At present, COVID-19 is causing secondary
outbreaks across the globe. The effective control of this
fatal outbreak is much dependent upon the isolation of
infected individuals and the quarantine of suspected
individuals. The current scenario indicates the need for
high-level public health interventions such as intensive
contact tracing as well as the implementation of rigorous
vigilance, prevention, and control measures for reducing
the transmission risks (Tang et al., 2020). However, the
continued increase in the confirmed cases, along with the
importation of matters to previously unaffected countries,
suggests the possible failure of our preventive strategies.
Hence, implementing strict public health measures will
not be sufficient enough to control and eliminate the threat
caused by COVID-19. Alternative approaches are required
to prevent the spread of COVID-19. Even though several
clinical trials are ongoing to identify and evaluate the
therapeutic and preventive potential of several drugs and
vaccines against SARS-CoV-2. However, more time will
be required for making the final product available to the
infected individuals. The development of specific antiviral
drugs against COVID-19 will help to limit the morbidity
and mortality while the vaccines and prophylactics will
help to prevent the occurrence of new cases (Park et al.,
2020).

13. Conclusion and prospects
In the last few decades, coronaviruses have represented a
continuous pandemic threat to humans, and yet another
outbreak caused by SARS-CoV-2 was firstly reported in
Wuhan, China. The disease got spread across the country,
and confirmed cases of SARS-CoV-2/COVID-19 had been
published now in more than 80 countries and thus posed
a “public health emergency of international concern.” This
virus presently attained a high-risk category status by
WHO. Community-based interventions such as school
dismissals, event cancellations, social distancing, and
the creation of staff plan to work remotely can help slow
down the spread of COVID-19 as there are currently no
vaccine and specific antiviral drugs available. Individuals
can take daily preventive measures, such as frequent
hand washing, staying at home when they are sick, and
coughing and sneezing (CDC, 2020; Wu and McGoogan,
2020). Besides, it has been recommended to avoid a visit
to live-animal markets. China has approved 10 detection
kits used for COVID-19. The rapid serological diagnostic
kit is being developed but not widely used (Report, 2020).
Detection of SARS-CoV-2 from respiratory secretions
by Quantitative Real-time RT-PCR (RT-qPCR) assay has
routinely been used. In the context of the current situation
in China, especially in Hubei province, for comprehensive
management of the outbreak, a combination of RT-qPCR
or NGS and clinical criteria may be more critical.
Outside China, a dramatic increase of COVID-19
cases has been observed in South Korea, Iran, Italy, Japan,
France, and Spain. There is a dire need for policies and
efforts at national, regional, and international to stop
further spreading of disease. Therefore, collaboration,
cooperation, exchange of outbreak experience and
response, strengthening of health facilities and disease
surveillance, cross border monitoring, and an effective
vaccine and treatment are needed. Furthermore, One
Health should be of great importance. Future research
studies and high investments are of significant concerns
and have high stress to prevent the next epidemic and
pandemic. Three areas need to be strengthened, a)
improvement of wildlife trade market biosecurity b)
identification and surveillance of high-risk pathogens
among wildlife c) surveillance among people who have
contact with wildlife or farm animals to avoid and prevent
any future spillover of diseases from animals to humans
(Daszak et al., 2020).
Acknowledgement
The authors acknowledge their respective institutes/
universities.
Conflict of Interest
The authors declare that there is no conflict of interest.

141

AHMAD et al. / Turk J Biol
References
Ahmad T, Hui J (2020). One Health Approach and Coronavirus
Disease 2019. Human Vaccines & Immunotherapeutics. doi:
10.1080/21645515.2020.1732168
Ahmad T, Khan M, Haroon, Musa TH, Nasir S et al. (2020a).
COVID-19: Zoonotic aspects. Travel Medicine and Infectious
Disease 101607: doi: 10.1016/j.tmaid.2020.101607
Ahmad T, Khan M, Khan FM, Hui J (2020b). Are we ready for
the new fatal Coronavirus: scenario of Pakistan? Human
Vaccines
&
Immunotherapeutics
2020b.
doi:
10.1080/21645515.2020.1724000
Bonfoh B, Schwabenbauer K, Wallinga D, Hartung J, Schelling E et
al. (2010). Human health hazards associated with livestock
production. In: Livestock in a Changing Landscape, Volume
1, Drivers, Consequences and Responses. Washington DC, US:
Island Press, pp. 197-220.
Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S et al.
(2020). The psychological impact of quarantine and how to
reduce it: rapid review of the evidence. Lancet. doi: 10.1016/
S0140-6736(20)30460-8
Brucker MC (2020). Novel Viruses, Zoonotic Infections, and Travel
Health. Nurs Womens Health [Internet].
Cadieux G, Buckeridge DL, Jacques A, Libman M, Dendukuri N et al.
(2012). Patient, physician, encounter, and billing characteristics
predict the accuracy of syndromic surveillance case definitions.
BMC Public Health 12: 166. doi: 10.1186/1471-2458-12-166
Centers for Disease Control and Prevention (CDCP) (2009).
National Institutes of Health. Biosafety in microbiological and
biomedical laboratories (BMBL). 5th ed. U.S. Department of
Health and Human Services: Public Health Service, Centers for
Disease Control and Prevention, National Institutes of Health.
Centers for Disease Control and Prevention (CDC) (2020). National
Center for Emerging and Zoonotic Infectious Diseases
(NCEZID) 2017. Atlanta, Georgia, USA: CDCP.
Centers for Disease Control and Prevention (CDC) (2020).
Preventing COVID-19 Spread in Communities. Atlanta,
Georgia, USA: CDCP.
China National Standards Committee (CNSC) (2020). Laboratorygeneral requirements for biosafety (GB19489-2008), 2008.
Coronavirus COVID-19 Global Cases (2020). COVID-19 Dashboard
by the Center for Systems Science and Engineering (CSSE) at
Johns Hopkins University (JHU).
Daszak P, Olival KJ, Li H (2020). A strategy to prevent future
pandemics similar to the 2019-nCoV outbreak. Biosafety and
Health. doi: 10.1016/j.bsheal.2020.01.003

Dhama K, Karthik K, Khandia R, Chakraborty S, Munjal A et al.
(2018). Advances in designing and developing vaccines, drugs,
and therapies to counter Ebola virus. Frontiers in Immunology
9: 1803. doi: 10.3389/fimmu.2018.01803
Dhama K, Sharun K, Tiwari R, Dadar M, Malik Y et al. (2020b).
COVID-19, an emerging coronavirus infection: Advances
and prospects in designing and developing vaccines,
immunotherapeutics and therapeutics. Human Vaccines &
Immunotherapeutics doi: 10.1080/21645515.2020.1735227
Dhama K, Sharun K, Tiwari R, Sircar S, Bhat S et al. (2020a).
Coronavirus disease 2019–COVID-19. Preprints 2020a;
2020030001. doi: 10.20944/preprints202003.0001.v1
Dhama K, Verma AK, Rajagunalan S, Deb R, Karthik K et al. (2012).
Swine flu is back again: A review. Pakistan Journal of Biological
Sciences 15 (21): 1001-1009. doi: 10.3923/pjbs.2012.1001.1009
FAO (2008). Soaring Food Prices: Facts, Perspectives, Impacts and
Actions Required. HLC/08/INF/1, High-Level Conference on
World Food Security: The Challenges of Climate Change and
Bioenergy. Rome, Italy.
Food and Drug Administration (FDA) (2020). Coronavirus
(COVID-19) Update: FDA Issues New Policy to Help Expedite
Availability of Diagnostics. Silver Spring, MD, USA: FDA.
Gao GF (2019). For a better world: biosafety strategies to protect
global health. Biosafety and Health 1 (1): 1-3. doi: 10.1016/j.
bsheal.2019.03.001
Gaudioso J, Zemlo T (2007). Survey of bioscience research practices
in Asia: implications for biosafety and biosecurity. Applied
Biosafety 12 (4): 260-267. doi: 10.1177/153567600701200408
GOV.UK. (2020). GuidanceCOVID-19: guidance for employers and
businesses. London, UK: GOV. UK.
Grodzki M, Ollivier J, Le Saux JC, Piquet JC, Noyer M et al.
(2012). Impact of Xynthia tempest on viral contamination of
shellfish. Applied and Environmental Microbiology 78 (9):
3508-3511. doi: 10.1128/AEM.07604-11
Groseclose SL, Buckeridge DL (2017). Public health surveillance
systems: recent advances in their use and evaluation. Annual
review of Public Health 38: 57-79. doi: 10.1146/annurevpublhealth-031816-044348
Habibi R, Burci GL, de Campos TC, Chirwa D, Cinà M et al.
(2020). Do not violate the International Health Regulations
during the COVID-19 outbreak. Lancet. doi: 10.1016/S01406736(20)30373-1

Dhama K, Chakraborty S, Kapoor S, Tiwari R, Kumar A et al. (2013).
One world, one health-veterinary perspectives. Advances in
Animal and Veterinary Sciences 1 (1): 5-13.

Harypursat V, Chen YK (2020). Six weeks into the 2019 coronavirus
disease (COVID-19) outbreak- it is time to consider strategies
to impede the emergence of new zoonotic infections. Chinese
Medical Journal. doi: 10.1097/CM9.0000000000000760

Dhama K, Chakraborty S, Tiwari R, Verma AK, Saminathan M et
al. (2014). A concept paper on novel technologies boosting
production and safeguarding health of humans and animals.
Research Opinions in Animal and Veterinary Sciences 4 (7):
353-370.

Heckert RA, Reed JC, Gmuender FK, Ellis M, Tonui W (2011).
International biosafety and biosecurity challenges:
Suggestions for developing sustainable capacity in lowresource countries. Applied Biosafety 16 (4): 223-230. doi:
10.1177/153567601101600404

142

AHMAD et al. / Turk J Biol
Howard CR, Fletcher NF (2012). Emerging virus diseases: can we
ever expect the unexpected? Emerging Microbes & Infections
1 (12): e46. doi: 10.1038/emi.2012.47

Morens DM, Folkers GK, Fauci AS (2004). The challenge of emerging
and re-emerging infectious diseases. Nature 430: 242-429. doi:
10.1038/nature02759.

Jalava K (2020). First respiratory transmitted food borne outbreak?
International Journal of Hygiene and Environmental Health
226: 113490. doi: 10.1016/j.ijheh.2020.113490

Moritsugu K, Miller Z (2020). Things You Should Know About the
Novel Coronavirus China Is “The Central Threat”: Pompeo|
Coronavirus Doctors Targeted! Death toll continues to rise in
China as countries scramble to tackle coronavirus outbreak 11
confirmed US coronavirus cases, experts warn of pandemic|
ABC News Coronavirus Outbreak: Interview with Anthony
Fauci, National Institute of Health 2020.

Jernigan DB (2020). Update: Public Health Response to the
Coronavirus Disease 2019 Outbreak-United States, February
24, 2020. Morbidity and Mortality Weekly Report 2020: 69(8).
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D et al. (2008).
Global trends in emerging infectious diseases. Nature 451: 990993. doi: 10.1038/nature06536
Khan N, Naushad M (2020). Effects of Corona Virus on the World
Community. SSRN Electronic Journal 3532001.
Kruk ME (2008). Emergency preparedness and public health
systems lessons for developing countries. American Journal
of Preventative Medicine 34: 529-534. doi: 10.1016/j.
amepre.2008.02.012
Li YY, Wang WN, Lei Y, Zhang B, Yang J et al. (2020). Comparison of
the clinical characteristics between RNA positive and negative
patients clinically diagnosed with 2019 novel coronavirus
pneumonia. ZhonghuaJie He He Hu Xi ZaZhi 43 (0): E023.
Chinese. doi: 10.3760/cma.j.cn112147-20200214-00095
Liu L, Wang T, Lu J (2016). The prevalence, origin, and prevention of
six human coronaviruses. Virologica Sinica 31 (1): 94-99. doi:
10.1007/s12250-015-3687-z
MacLaren G, Fisher D, Brodie D (2020). Preparing for the Most
Critically Ill Patients with COVID-19: The Potential Role
of Extracorporeal Membrane Oxygenation. Journal of the
American Medical Association. doi: 10.1001/jama.2020.2342
Makam AN, Nguyen OK, Moore B, Ma Y, Amarasingham R (2013).
Identifying patients with diabetes and the earliest data of
diagnosis in real time: an electronic health record case-finding
algorithm. BMC Medical Informatics and Decision Making 13:
81. doi: 10.1186/1472-6947-13-81
Malik YS, Sircar S, Bhat S, Sharun K, Dhama K et al. (2020).
Emerging novel Coronavirus (2019-nCoV)-Current scenario,
evolutionary perspective based on genome analysis and
recent developments. Veterinary Quarterly 40: 68-76. doi:
10.1080/01652176.2020.1727993
Mallapaty S (2020). China set to clamp down permanently on
wildlife trade in wake of coronavirus. Nature. doi: 10.1038/
d41586-020-00499-2
Midgley SE, Bányai K, Buesa J, Halaihel N, Hjulsager CK et al. (2012).
Diversity and zoonotic potential of rotaviruses in swine and
cattle across Europe. Veterinary Microbiology 156 (3): 238245. doi: 10.1016/j.vetmic.2011.10.027
Mikkelson D (2020). Did a Coronavirus Bulletin Warn Against
Unprotected Sex with Farm Animals? You can take the virus
out of the farm, but you can’t.
Moratelli R, Calisher CH (2015). Bats and zoonotic viruses: can we
confidently link bats with emerging deadly viruses? Memórias
do Instituto Oswaldo Cruz 110: 1-22.

Mourya DT, Yadav PD, Ullas PT, Bhardwaj SD, Sahay RR et al.
(2019). Emerging/re-emerging viral diseases & new viruses on
the Indian horizon. Indian Journal of Medical Research 149
(4): 447. doi: 10.4103/ijmr.IJMR_1239_18
Munjal A, Khandia R, Dhama K, Sachan S, Karthik K et al. (2017).
Advances in developing therapies to combat Zika virus: current
knowledge and future perspectives. Frontiers Microbiology 8:
1469. doi: 10.3389/fmicb.2017.01469
Murdoch DR, French NP (2020). COVID-19: another infectious
disease emerging at the animal-human interface. The New
Zealand Medical Journal 133(1510): 12-15.
National Center for Immunization and Respiratory Diseases
(NCIRD) (2020). Division of Viral Diseases. Atlanta, Georgia,
USA: NCIRD.
Nkengasong J (2020). China’s response to a novel coronavirus stands
in stark contrast to the 2002 SARS outbreak response. Nature
Medicine. doi: 10.1038/s41591-020-0771-1
Nkengasong JN, Mankoula W (2020). Looming threat of COVID-19
infection in Africa: act collectively, and fast. Lancet 2020. doi:
10.1016/S0140-6736(20)30464-5
Painter J (2013). Attribution of Foodborne Illnesses, Hospitalizations,
and Deaths to Food Commodities by using Outbreak Data,
United States, 1998–2008. Emerging Infectious Diseases 19 (3):
407-415. doi: 10.3201/eid1903.111866
Pan Y, Zhang D, Yang P, Poon LLM, Wang Q (2020). Viral load of
SARS-CoV-2 in clinical samples. Lancet Infectious Diseases.
doi: 10.1016/S1473-3099(20)30113-4
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G,
Sourvinos G et al. (2020). Full-genome evolutionary analysis
of the novel corona virus (2019-nCoV) rejects the hypothesis
of emergence as a result of a recent recombination event.
Infection, Genetics and Evolution 79: 104212. doi: 10.1016/j.
meegid.2020.104212
Park M, Thwaites RS, Openshaw PJM (2020). COVID-19: Lessons
from SARS and MERS. European Journal of Immunology. doi:
10.1002/eji.202070035
Parker ER, Pate P (2005). Implementing UN Security Council
Resolution 1540 to Combat the Proliferation of Biological
Weapons. Biosecurity and Bioterrorism: Biodefense Strategy,
Practice, and Science 3 (2). doi: 10.1089/bsp.2005.3.166
Perlman S (2020). Another decade, another coronavirus. The New
England Journal of Medicine 382 (8): 760-762.

143

AHMAD et al. / Turk J Biol
Pew Research Center (PRC) (2020). The Future of Well-Being in a
Tech-Saturated World.
Rabinowitz P, Gordon Z, Chudnov D, Wilcox M, Odofin L et
al. (2006). Animals as sentinels of bioterrorism agents.
Emerging Infectious Diseases 12 (4): 647-652. doi: 10.3201/
eid1204.051120
Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ (2020).
Coronavirus Disease 2019 (COVID-19) and Pregnancy: What
obstetricians need to know: American Journal of Obstetrics
and Gynecology. doi: 10.1016/j.ajog.2020.02.017
Rath J, Ischi M, Perkins D (2014). Evolution of different dual-use
concepts in international and national law and its implications
on research ethics and governance. Science and Engineering
Ethics 20 (3): 769-790. doi: 10.1007/s11948-014-9519-y

To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC et al. (2020).
Consistent detection of 2019 novel coronavirus in saliva.
Clinical Infectious Diseases 149. doi: 10.1093/cid/ciaa149
Today (2020). Thailand finds second case of new Chinese virus, says
no outbreak.
Tong J, Liu M, Shen Y, Guo D (2020). Evaluation of coronavirus in
tears and conjunctival secretions of patients with SARS-CoV-2
infection. Journal of Medical Virology. 10.1002/jmv.25725. doi:
10.1002/jmv.25725
United Nations (2020). UN Security Council Resolution 1540 (2004).
New York, NY, USA: UN.
vanUhm D (2016). The Illegal Wildlife Trade. Switzerland: Springer.
doi: 10.1007/978-3-319-42129-2

WHO (2020). Report of the WHO-China Joint Mission on
Coronavirus Disease 2019 (COVID-19). Geneva, Switzerland:
WHO.

Wang R, Zhang X, Irwin DM, Shen Y (2020). Emergence of SARSlike Coronavirus poses new challenge in China. Journal of
Infection. doi: 10.1016/j.jinf.2020.01.017

Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ,
Rabaan AA, Sah R et al. (2020). History is repeating itself:
Probable zoonotic spillover as the cause of the 2019 novel
Coronavirus Epidemic. Infez Med 28 (1): 3-5.

Wertheim HFL, Puthavathana P, Nghiem NM, Van Doorn HR,
Nguyen TV (2010). Laboratory capacity building in Asia
for infectious disease research: Experiences from the South
East Asia Infectious Disease Clinical Research Network
(SEAICRN). PLoS Medicine 7 (4): e1000231. doi: 10.1371/
journal.pmed.1000231

Salata C, Calistri A, Parolin C, Palù G (2020). Coronaviruses: a
paradigm of new emerging zoonotic diseases. Pathogens and
Disease 77 (9): ftaa006. doi: 10.1093/femspd/ftaa006
Salerno RM, Gaudioso J, Brodsky BH (2007). Laboratory biosecurity
handbook. FL, USA: CRC Press.
Scanes CG (2020). Chapter 14 - Animals and Human Disease:
Zoonosis, Vectors, Food-Borne Diseases, and Allergies. In:
Scanes CG, Toukhsati SRBT-A and HS (editors). Cambridge,
MA, USA: Academic Press, pp. 331-354.
Seto WH, Conly JM, Pessoa-Silva CL, Malik M. Eremin S
(2013). Infection prevention and control measures for acute
respiratory infections in healthcare settings: an update. Eastern
Mediterranean Health Journal 19: S39-S47.
Shen K, Yang Y, Wang T, Zhao D, Jiang Y et al. (2020). Diagnosis,
treatment, and prevention of 2019 novel coronavirus infection
in children: experts’ consensus statement. World Journal
Podiatry. doi: 10.1007/s12519-020-00343-7
Singh RB (2009). Biosecurity for food security. Souvenir–IndiaAfrica Cooperation for Sustainable Food Security. doi:
10.3201/eid1204.051120
Singh RK, Dhama K, Chakraborty S, Tiwari R, Natesan S et al. (2019).
Nipah virus: epidemiology, pathology, immunobiology and
advances in diagnosis, vaccine designing and control strategies
- a comprehensive review. Veterinary Quarterly 39 (1): 26-55.
doi: 10.1080/01652176.2019.1580827
Tang B, Wang X, Li Q, Bragazzi NL, Tang S et al. (2020). Estimation
of the transmission risk of the 2019-nCoV and its implication
for public health interventions. Clinical Medicine 9 (2): E462.
doi: 10.3390/jcm9020462
The PLoS Medicine Editors (2007). How is WHO responding to
global public health threats? PLoS Medicine 4 (5): e197. doi:
10.1371/journal.pmed.0040197

144

Wilder-Smith A, Freedman DO (2020). Isolation, quarantine, social
distancing and community containment: pivotal role for oldstyle public health measures in the novel coronavirus (2019nCoV) outbreak. Journal of Travel Medicine. doi: 10.1093/jtm/
taaa020
Wilson ME, Chen LH (2020). Travellers Give Wings to Novel
Coronavirus (2019-nCoV). Journal of Travel Medicine. doi:
10.1093/jtm/taaa015
Woo PCY, Lau SKP, Lam CSF, Lau CCY, Tsang AKL et al. (2012).
Discovery of seven novel Mammalian and avian coronaviruses
in the genus deltacoronavirus supports bat coronaviruses as
the gene source of alphacoronavirus and betacoronavirus and
avian coronaviruses as the gene source of gammacoronavirus
and deltacoronavirus. Journal of Virology 86 (7): 3995-4008.
doi: 10.1128/JVI.06540-11
World Economic Forum (WEF) (2020). The economic effects of
the COVID-19 coronavirus around the world. Cologny,
Switzerland: WEF.
World Health Assembly (WHA) (2020). Strengthening pandemicinfluenza preparedness and response: WHA58.5 2005. Geneva,
Switzerland: WHA.
World Health Organization (WHO) (2020a). Global Influenza
Surveillance Network Manual for the laboratory diagnosis and
virological surveillance of influenza 2011. Geneva, Switzerland:
WHO.
World Health Organization (WHO) (2020b). Update on COVID-19
in the Eastern Mediterranean Region. Geneva, Switzerland:
WHO
World Health Organization (WHO) (2020c). Laboratory Biosafety
Manual (3rd ed), Geneva, 2004. Geneva, Switzerland: WHO

AHMAD et al. / Turk J Biol
World Organization for Animal Health (WOAH) (2015). Biological
Threat Reduction Strategy, Strengthening Global Biological
Security. In: OIE Global Conference on Biological Threat
Reduction; Paris, France.
Wu Z, McGoogan JM (2020). Characteristics of and Important
Lessons from the Coronavirus Disease 2019 (COVID-19)
Outbreak in China: Summary of a Report of 72 314
Cases From the Chinese Center for Disease Control and
Prevention. Journal of the American Medical Association. doi:
10.1001/jama.2020.2648
Zhang W, Du RH, Li B, Zheng XS, Yang XL et al. (2020).
Molecular and serological investigation of 2019-nCoV
infected patients: implication of multiple shedding routes.
Emerging Microbes & Infections 9 (1): 386-389. doi:
10.1080/22221751.2020.1729071

Zhiming Y (2019). Current status and future challenges of highlevel biosafety laboratories in China. Journal of Biosafety and
Biosecurity 1: 123-127. doi: 10.1016/j.jobb.2019.09.005
Zhou P, Yang X-L, Wang XG, Hu B, Zhang L et al. (2020). A
pneumonia outbreak associated with a new coronavirus of
probable bat origin. Nature. doi: 10.1038/s41586-020-2012-7
Zhu N, Zhang D, Wang W, Li X, Yang B et al. (2019). A Novel
Coronavirus from Patients with Pneumonia in China,
2019. New England Journal of Medicine. doi: 10.1056/
NEJMoa2001017
Zou L, Ruan F, Huang M, Liang L, Huang H et al. (2020). SARSCoV-2 Viral Load in Upper Respiratory Specimens of Infected
Patients. New England Journal of Medicine. doi: 10.1056/
NEJMc2001737

145

